JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.28% |
| 2 | Technology | 17.17% |
| 3 | Healthcare | 10.79% |
| 4 | Financials | 9.36% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
TRVG
5501
trivago
TRVG
$334M
| $43K | ﹤0.01% |
+5,637
| New | +$46.2K |
2023 Q1
0 quarters
|
|
5502
Reaves Utility Income Fund
UTG
$3.25B
| $43K | ﹤0.01% |
1,509
+1,095
| +264% | +$31.4K |
2021 Q3
6 quarters
|
|
|
DOMA
5503
DELISTED
Doma Holdings, Inc.
DOMA
| $43K | ﹤0.01% |
4,261
+1,155
| +37% | +$15.5K |
2021 Q1
8 quarters
|
|
|
UDEC
5504
Innovator US Equity Ultra Buffer ETF December
UDEC
$243M
| $42.8K | ﹤0.01% |
1,500
| – | – |
2022 Q4
1 quarter
|
|
5505
PIMCO RAFI Dynamic Multi-Factor US Equity ETF
MFUS
$302M
| $42.6K | ﹤0.01% |
1,113
+521
| +88% | +$20.1K |
2022 Q4
1 quarter
|
|
5506
First Trust Lunt US Factor Rotation ETF
FCTR
$53.2M
| $42.1K | ﹤0.01% |
1,536
-1
| -0.1% | -$28 |
2022 Q4
1 quarter
|
|
5507
Innovator Defined Wealth Shield ETF
BALT
$3.01B
| $42K | ﹤0.01% |
+1,543
| New | +$41.5K |
2023 Q1
0 quarters
|
|
5508
CALL
ChargePoint
CHPT
$240M
| $42K | ﹤0.01% |
+200
| New | +$43.6K |
2023 Q1
0 quarters
|
|
|
5509
PUT
ChargePoint
CHPT
$240M
| $42K | ﹤0.01% |
200
+120
| +150% | +$26.1K |
2022 Q4
1 quarter
|
|
|
AXIA
5510
DELISTED
AXIA Energia
AXIA
| $42K | ﹤0.01% |
8,028
-33,355
| -81% | -$186K |
2016 Q4
25 quarters
|
|
|
ELEV
5511
DELISTED
Elevation Oncology
ELEV
| $42K | ﹤0.01% |
22,347
+18,107
| +427% | +$23.4K |
2022 Q4
1 quarter
|
|
5512
First Trust Institutional Preferred Securities and Income ETF
FPEI
$1.86B
| $42K | ﹤0.01% |
+2,526
| New | +$45.4K |
2023 Q1
0 quarters
|
|
|
NIE
5513
Virtus Equity & Convertible Income Fund
NIE
$688M
| $42K | ﹤0.01% |
+2,154
| New | +$42.2K |
2023 Q1
0 quarters
|
|
5514
Nuveen New York Municipal Value Fund
NNY
$149M
| $42K | ﹤0.01% |
+4,849
| New | +$41.2K |
2023 Q1
0 quarters
|
|
5515
Pacer Swan SOS Conservative April ETF
PSCW
$61.5M
| $42K | ﹤0.01% |
+2,000
| New | +$41.8K |
2023 Q1
0 quarters
|
|
5516
Transcontinental Realty Investors
TCI
$399M
| $42K | ﹤0.01% |
996
+138
| +16% | +$6.14K |
2017 Q4
21 quarters
|
|
|
CTIC
5517
CALL
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $42K | ﹤0.01% |
+10,000
| New | +$51.9K |
2023 Q1
0 quarters
|
|
5518
iShares Future Exponential Technologies ETF
XT
$4.06B
| $41.9K | ﹤0.01% |
796
+190
| +31% | +$9.77K |
2022 Q3
2 quarters
|
|
5519
ALPS O'Shares US Small-Cap Quality Dividend ETF
OUSM
$789M
| $41.9K | ﹤0.01% |
+1,185
| New | +$42K |
2023 Q1
0 quarters
|
|
|
CHY
5520
Calamos Convertible and High Income Fund
CHY
$938M
| $41.4K | ﹤0.01% |
3,766
+3,700
| +5,606% | +$43.9K |
2022 Q2
3 quarters
|
|
5521
ProShares S&P SmallCap 600 Dividend Aristocrats ETF
SMDV
$657M
| $41.3K | ﹤0.01% |
677
-17,841
| -96% | -$1.13M |
2022 Q4
1 quarter
|
|
|
LSEAW
5522
DELISTED
Landsea Homes Corporation Warrant
LSEAW
| – | – |
0
| – | – |
2021 Q2
7 quarters
|
|
5523
Invesco Russell 2000 Dynamic Multifactor ETF
OMFS
$268M
| $41K | ﹤0.01% |
+1,160
| New | +$42K |
2023 Q1
0 quarters
|
|
5524
PUT
Vanguard FTSE Developed Markets ETF
VEA
$232B
| $41K | ﹤0.01% |
900
-81,400
| -99% | -$3.63M |
2022 Q4
1 quarter
|
|
5525
Invesco AI and Next Gen Software ETF
IGPT
$1.47B
| $40.2K | ﹤0.01% |
1,200
-672
| -36% | -$21.5K |
2019 Q2
15 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 751 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 751 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.